First AD

Second AD

Shubham Pant, MD, MBBS, is a professor in the Department of Gastrointestinal Medical Oncology in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center 

Future Perspectives and Unmet Needs in HER2-Positive Advanced BTC Treatment

Video content above is prompted by the following:

What are some remaining unmet needs for those with HER2, advanced BTC?

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Video Series

Exploring Biliary Tract Cancer: Top Takeaways From ASCO GI 2025 

Peer Exchange

Panelists discuss how significant challenges remain in HER2-positive biliary tract cancer (BTC), including optimizing sequencing of targeted therapies, addressing resistance mechanisms, improving biomarker testing accessibility, and developing strategies for brain metastases.